Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to $186504.0.

  • Arcadia Biosciences' Gains from Investment Securities fell 1428.06% to $186504.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $186504.0, marking a year-over-year decrease of 1428.06%. This contributed to the annual value of $205475.0 for FY2024, which is 15659.36% up from last year.
  • According to the latest figures from Q3 2025, Arcadia Biosciences' Gains from Investment Securities is $186504.0, which was down 1428.06% from $213950.0 recorded in Q2 2025.
  • Arcadia Biosciences' Gains from Investment Securities' 5-year high stood at $1.7 million during Q2 2021, with a 5-year trough of -$322000.0 in Q1 2021.
  • Over the past 5 years, Arcadia Biosciences' median Gains from Investment Securities value was $76682.0 (recorded in 2024), while the average stood at $165813.2.
  • As far as peak fluctuations go, Arcadia Biosciences' Gains from Investment Securities crashed by 13687.36% in 2021, and later surged by 31732.05% in 2023.
  • Over the past 5 years, Arcadia Biosciences' Gains from Investment Securities (Quarter) stood at $2000.0 in 2021, then crashed by 2050.0% to -$39000.0 in 2022, then skyrocketed by 61.54% to -$15000.0 in 2023, then surged by 1550.5% to $217575.0 in 2024, then decreased by 14.28% to $186504.0 in 2025.
  • Its Gains from Investment Securities stands at $186504.0 for Q3 2025, versus $213950.0 for Q2 2025 and $191511.0 for Q1 2025.